Cargando...
Aptamers: A New Technological Platform in Cancer Immunotherapy
The renaissance of cancer immunotherapy is, nowadays, a reality. In the near future, it will be very likely among the first-line treatments for cancer patients. There are several different approaches to modulate the immune system to fight against tumor maladies but, so far, monoclonal antibodies may...
Gardado en:
| Publicado en: | Pharmaceuticals (Basel) |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5198039/ https://ncbi.nlm.nih.gov/pubmed/27783034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph9040064 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|